MariMed, Inc. (MRMD)
0.0634
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
MariMed Net Income (Quarterly) : -3.571M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.571M |
| March 31, 2026 | -3.767M |
| December 31, 2025 | -4.641M |
| September 30, 2025 | -2.941M |
| June 30, 2025 | -1.395M |
| March 31, 2025 | -5.479M |
| December 31, 2024 | -8.264M |
| September 30, 2024 | -0.995M |
| June 30, 2024 | -1.639M |
| March 31, 2024 | -1.292M |
| December 31, 2023 | -10.14M |
| September 30, 2023 | -4.269M |
| June 30, 2023 | -0.981M |
| March 31, 2023 | -0.664M |
| December 31, 2022 | 4.755M |
| September 30, 2022 | 2.722M |
| June 30, 2022 | 1.896M |
| March 31, 2022 | 4.241M |
| December 31, 2021 | -6.398M |
| September 30, 2021 | 2.123M |
| June 30, 2021 | 7.589M |
| March 31, 2021 | 4.31M |
| December 31, 2020 | 4.212M |
| September 30, 2020 | 1.696M |
| June 30, 2020 | -1.141M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.338M |
| December 31, 2019 | -79.38M |
| September 30, 2019 | -7.300M |
| June 30, 2019 | 4.723M |
| March 31, 2019 | 0.078M |
| December 31, 2018 | 4.913M |
| September 30, 2018 | -3.412M |
| June 30, 2018 | -0.3927M |
| March 31, 2018 | -1.832M |
| December 31, 2017 | -1.329M |
| September 30, 2017 | -0.314M |
| June 30, 2017 | 0.5048M |
| March 31, 2017 | 0.1094M |
| December 31, 2016 | 0.3486M |
| September 30, 2016 | -0.0069M |
| June 30, 2016 | 0.039M |
| March 31, 2016 | -0.0618M |
| December 31, 2015 | -1.060M |
| September 30, 2015 | -0.0569M |
| June 30, 2015 | -0.4111M |
| March 31, 2015 | -0.319M |
| December 31, 2014 | -0.5258M |
| September 30, 2014 | -6.638M |
| June 30, 2014 | -0.1252M |
| March 31, 2014 | -0.132M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Omeros Corp. | 6.637M |
| Talphera, Inc. | -4.312M |
| Hyperion DeFi, Inc. | 30.95M |
| Atea Pharmaceuticals, Inc. | -32.93M |
| Cencora, Inc. | 776.67M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 41.92M |
| Total Expenses (Quarterly) | 45.51M |
| EPS Diluted (Quarterly) | -0.009 |
| Enterprise Value | 112.68M |
| Gross Profit Margin (Quarterly) | 20.87% |
| Profit Margin (Quarterly) | -8.52% |
| Earnings Yield | -59.51% |
| Normalized Earnings Yield | -59.98 |